https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb2376
Asciminib - Oral
asciminiboral
https://www.ncbi.nlm.nih.gov/books/NBK501922/?term=ASCIMINIB
ASCIMINIB - Books - NCBI
asciminibbooksncbi
https://scholars.uky.edu/es/projects/an-open-label-multi-center-phase-iiib-study-of-asciminib-abl001-m-2/
An Open Label, Multi-Center Phase IIIb Study of Asciminib (ABL001) Monotherapy in Previously...
https://pubmed.ncbi.nlm.nih.gov/40019625/
Population pharmacokinetic modeling of asciminib in support of exposure-response and ethnic...
The 40 mg b.i.d. and 80 mg q.d. regimens are comparable in their daily exposure, supporting the use of the two dosing regimens in newly diagnosed and...
in supportpopulationpharmacokineticmodelingasciminib
https://www.scemblix-hcp.com/
Ph+ CML-CP | SCEMBLIX® (asciminib) Tablets | HCP
Learn about SCEMBLIX, a treatment option for adult patients with newly diagnosed or previously treated Ph+ CML-CP. See full Prescribing and Safety Information.
phcmlcpasciminibtablets
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e33001e7-3650-42b1-ae56-cddb5c43aa2b
DailyMed - SCEMBLIX- asciminib tablet, film coated
dailymedasciminibtabletfilmcoated